![David Sheppard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David William Sheppard is currently Chief Executive Officer at HotHouse Therapeutics Ltd. since 2024 and Director at Revona Bio Ltd. since 2023.
Formerly, Dr. Sheppard was Director at Entact Bio Ltd. from 2019 to 2022.
| Unternehmen | Position | Beginn |
|---|---|---|
Revona Bio Ltd.
 Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused on development RNA targeted drugs | Direktor/Vorstandsmitglied | 05.04.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Develops cancer immune therapy | Direktor/Vorstandsmitglied | 09.07.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Develops cancer immune therapy | Health Technology |
Revona Bio Ltd.
Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused on development RNA targeted drugs | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
